Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CORT108297 in Veterans with PTSD
NCT04452500Phase 2Completed
- Sponsor
- VA Office of Research & Development
- Start
- Oct 2022
- Primary completion
- Jul 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of cort108297 in post-traumatic stress disorder (PTSD), sponsored by VA Office of Research & Development. Started Oct 2022; status: completed.
02
Drugs
cort108297
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT04452500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04452500.